These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Studies on renomedullary prostaglandin and renal kallikrein-kinin system in hypertension. Abe K; Seino M; Yasujima M; Chiba S; Sakurai Y Jpn Circ J; 1977 Aug; 41(8):873-80. PubMed ID: 909128 [No Abstract] [Full Text] [Related]
24. [Changes in urinary prostaglandin excretion in hypertension patients undergoing variants of furosemide administration]. Dzhusipov AK; Nekrasova AA Ter Arkh; 1984; 56(4):90-4. PubMed ID: 6587605 [No Abstract] [Full Text] [Related]
25. Atrial natriuretic factor and urinary kallikrein in the rat: antagonistic factors? Thibault G; Garcia R; Cantin M; Genest J Can J Physiol Pharmacol; 1984 Jun; 62(6):645-9. PubMed ID: 6204730 [TBL] [Abstract][Full Text] [Related]
26. Furosemide compounds enhance urinary excretion of active kallikrein independently of their effects on urinary electrolyte excretion. Bulmer B; Penschow JD Exp Nephrol; 1998; 6(4):320-7. PubMed ID: 9690095 [TBL] [Abstract][Full Text] [Related]
27. Renal kallikrein and PGE in the exaggerated fractional Na excretion in patients with chronic renal failure. Abe K; Haruyama T; Sato M; Imai Y; Yasujima M; Seino M; Chiba S; Hiwatari M; Kasai Y; Tajima J; Itoh S; Yoshinaga K Adv Exp Med Biol; 1983; 156 (Pt B)():977-84. PubMed ID: 6344585 [TBL] [Abstract][Full Text] [Related]
28. Sodium, water and kallikrein excretion in man. Margolius HS; Horwitz D; Pisano JJ; Keiser HR Acta Physiol Lat Am; 1974; 24(5):464-8. PubMed ID: 4467673 [No Abstract] [Full Text] [Related]
29. A circadian variation in the excretion of urinary kinin, kallikrein and prostaglandin E in normal volunteers. Abe K; Sato M; Kasai Y; Haruyama T; Sato K; Miyazaki S; Imai Y; Hiwatari M; Itoh T; Sakurai Y; Goto T; Tajima J; Seino M; Yoshinaga K Jpn Circ J; 1981 Sep; 45(9):1098-103. PubMed ID: 7029030 [TBL] [Abstract][Full Text] [Related]
30. Long-term effects of aldosterone on kallikrein, prostaglandin E2 and sodium in rats. Yasujima M; Abe K; Tanno M; Kohzuki M; Kanazawa M; Omata K; Kasai Y; Sato M; Takeuchi K; Itoh S Tohoku J Exp Med; 1987 Aug; 152(4):351-62. PubMed ID: 3477885 [TBL] [Abstract][Full Text] [Related]
31. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension. Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385 [No Abstract] [Full Text] [Related]
32. Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance. Pinzani M; Daskalopoulos G; Laffi G; Gentilini P; Zipser RD Gastroenterology; 1987 Feb; 92(2):294-8. PubMed ID: 3466836 [TBL] [Abstract][Full Text] [Related]
33. Active and inactive urinary kallikrein in man: effects of diuresis and antidiuresis. Waller DG; Bhatia SS; Campbell SK; Albano JD; Millar JG Clin Sci (Lond); 1990 Aug; 79(2):117-21. PubMed ID: 2167800 [TBL] [Abstract][Full Text] [Related]
34. Different effects of furosemide on urinary excretion of prostaglandin E2 and F2 alpha in rabbits. Oliw E; AnggÄrd E Acta Physiol Scand; 1979 Mar; 105(3):367-73. PubMed ID: 443065 [TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E synthesis in the kidney in renin subgroups of essential hypertension. Sato K; Abe K; Sato M; Haruyama T; Yasujima M; Hiwatari M; Tajima J; Kasai Y; Chiba S; Seino M; Yoshinaga K Prostaglandins Leukot Med; 1982 Nov; 9(5):577-85. PubMed ID: 6757970 [TBL] [Abstract][Full Text] [Related]
36. The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension. Abe K; Yasujima M; Irokawa N; Seino M; Chiba S; Sakurai Y; Sato M; Imai Y; Saito K; Ito T; Haruyama T; Otsuka Y; Yoshinaga K Clin Sci Mol Med Suppl; 1978 Dec; 4():363s-366s. PubMed ID: 282087 [No Abstract] [Full Text] [Related]
37. Exaggerated fractional sodium excretion in hypertension with advanced renal disease: the role of renal prostaglandin and kallikrein. Abe K; Imai Y; Sato M; Haruyama T; Sato K; Hiwatari M; Kasai Y; Itoh S; Yasujima M; Seino M; Yoshinaga K Clin Sci (Lond); 1981 Dec; 61 Suppl 7():327s-330s. PubMed ID: 6914940 [TBL] [Abstract][Full Text] [Related]
39. Chronic effects of norepinephrine and vasopressin on urinary prostaglandin E and kallikrein excretions in conscious rats. Yasujima M; Abe K; Tanno M; Sato K; Kasai Y; Seino M; Chiba S; Goto T; Omata K; Tajima J Clin Exp Hypertens A; 1984; 6(7):1297-310. PubMed ID: 6565534 [TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans. Okaniwa T; Echizen H; Ishizaki T; Kasao M; Iizuka T J Pharmacol Exp Ther; 1990 Nov; 255(2):716-23. PubMed ID: 2147037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]